切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2011, Vol. 05 ›› Issue (02) : 140 -143. doi: 10.3877/cma.j.issn.1674-0793.2011.02.013

所属专题: 文献

论著

乳腺癌患者血清中巨噬细胞移动抑制因子的临床意义
徐向东1, 汪波2, 姚陈1, 林颖1, 王深明1,()   
  1. 1. 510080 广州,中山大学附属第一医院乳腺病治疗中心
    2. 510080 广州,中山大学附属第一医院检验科
  • 收稿日期:2010-12-08 出版日期:2011-04-01
  • 通信作者: 王深明

Serum levels of macrophage migration inhibitory factor in patients with breast cancer and its clinical significance

Xiang-dong XU1, Bo WANG2, Chen YAO1, Ying LIN1, Shen-ming WANG1,()   

  1. 1. Center of Breast Disease, the First Affiliated Hospital, SUN Yat-Sen University, Guangzhou 510080, China
  • Received:2010-12-08 Published:2011-04-01
  • Corresponding author: Shen-ming WANG
  • About author:
    Corresponding author: WANG Shen-ming, Email:
引用本文:

徐向东, 汪波, 姚陈, 林颖, 王深明. 乳腺癌患者血清中巨噬细胞移动抑制因子的临床意义[J/OL]. 中华普通外科学文献(电子版), 2011, 05(02): 140-143.

Xiang-dong XU, Bo WANG, Chen YAO, Ying LIN, Shen-ming WANG. Serum levels of macrophage migration inhibitory factor in patients with breast cancer and its clinical significance[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2011, 05(02): 140-143.

目的

探讨乳腺癌患者血清巨噬细胞移动抑制因子(MIF)水平与其临床特征的关系。

方法

收集2006年10月至2007年3月乳腺癌患者54例和体检正常的女性健康对照46例血清,用酶联免疫吸附法检测血清MIF、白细胞介素8(IL-8)及血管内皮生长因子(VEGF)的浓度,分析其与临床特征的关系。

结果

乳腺癌组血清MIF、IL-8及VEGF浓度均明显高于健康对照组(P<0.05),MIF与肿瘤的分期和淋巴结转移相关(P<0.05),乳腺癌组患者血清MIF与IL-8相关(r=0.612,P<0.01)。

结论

MIF可能参与了乳腺癌的疾病进展过程,可作为反应肿瘤侵袭的一个有用的生物标记物。

Objective

To study the relationship between serum macrophage migration inhibitory factor (MIF) levels and clinical features in the patients with breast cancer.

Methods

Enzyme-linked immunosorbent assay was used to detect the concentration of MIF, IL-8 and VEGF in sera of 54 patients with breast cancer and 46 healthy controls from October 2006 to March 2007.The relationship between serum MIF, IL-8 and VEGF levels and clinical features was analyzed.

Results

The levels of MIF, IL-8 and VEGF in the sera of patients with breast cancer were significantly increased compared to healthy controls(P<0.05). The levels of MIF in breast cancer were significantly correlated with clinical progression pathology stages(P<0.05) and lymph node metastasis(P<0.05). Serum MIF levels correlated positively with serum IL-8 levels (r=0.612, P<0.01).

Conclusion

MIF may be involved in the progression of breast cancer and serum MIF may be a useful biological marker of tumor invasiveness for patients with breast cancer.

表1 两组患者血清中MIF、IL-8及VEGF蛋白水平
表2 乳腺癌患者临床病理特征与MIF表达的关系
1
Agarwal R, Whang DH, Alvero AB, et al. Macrophage migration inhibitory factor expression in ovarian cancer. Am J Obstet Gynecol, 2007, 196(4): 348.e1-5.
2
Suzuki F, Nakamaru Y, Oridate N, et al. Prognostic significance of cytoplasmic macrophage migration inhibitory factor expression in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy. Oncol Rep, 2005, 13(1): 59-64.
3
Hira E, Ono T, Dhar DK, et al. Overexpression of macrophage migration inhibitory factor induces angiogenesis and deteriorates prognosis after radical resection for hepatocellular carcinoma. Cancer, 2005, 103(3): 588-598.
4
He XX, Yang J, Ding YW, et al. Increased epithelial and serum expression of macrophage migration inhibitory factor (MIF) in gastric cancer: potential role of MIF in gastric carcinogenesis. Gut, 2006, 55(6): 797-802.
5
Ren Y, Chan HM, Fan J, et al. Inhibition of tumor growth and metastasis in vitro and in vivo by targeting macrophage migration inhibitory factor in human neuroblastoma. Oncogene, 2006, 25: 3501-3508.
6
徐向东, 姚陈, 林颖, 等. 乳腺癌组织中巨噬细胞移动抑制因子表达与预后的关系. 中华外科杂志, 2008, 88(8): 520-523.
7
Bando H, Matsumoto G, Bando M, et al. Expression of macrophage migration inhibitory factor in human breast cancer: association with nodal spread. Jpn J Cancer Res, 2002, 93(4): 389-396.
8
王东, 刘敏, 李雯, 等. 原发性肝细胞癌患者血清巨噬细胞移动抑制因子水平与血管内皮生长因子和临床病理的关系. 中华检验医学杂志, 2009, 32(9): 1011-1014.
9
Benoy IH, Salgado R, Van Dam P, et al. Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival. Clin Cancer Res, 2004, 10(21): 7157-7162.
10
Poon RT, Fan ST, Wong J. Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol, 2001, 19(4): 1207-1225.
11
XD Xu, Bo Wang, Cai Sheng Ye, et al. Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer. Cancer letters, 2008, 261(2): 147-157.
12
Ren Y, Law S, Huang X, et al. Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma. Ann Surg, 2005, 242(1): 55-63.
13
White ES, Flaherty KR, Carskadon S, et al. Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis. Clin Cancer Res, 2003, 9(2): 853-860.
[1] 洪玮, 叶细容, 刘枝红, 杨银凤, 吕志红. 超声影像组学联合临床病理特征预测乳腺癌新辅助化疗完全病理缓解的价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 571-579.
[2] 赵阳, 肖迎聪, 巨艳, 党晓智, 蔡林利, 薛文欣, 李洋, 肖瑶, 郭妤绮, 宋宏萍. 自动乳腺超声联合免疫组化早期预测乳腺癌新辅助化疗病理完全缓解的临床价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(04): 361-369.
[3] 刘伟, 牛云峰, 安杰. LINC01232 通过miR-516a-5p/BCL9 轴促进三阴性乳腺癌的恶性进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 330-338.
[4] 杨柳, 宋振川, 王新乐. 乳腺癌改良根治术联合背阔肌复位的临床疗效评估[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 269-273.
[5] 牛海刚, 郭文科. 三阴性乳腺癌组织中双特异性磷酸酶14与核受体相互作用蛋白1的表达及预后价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(04): 199-205.
[6] 唐丹萍, 王萍, 江孟蝶, 杨晓蓉. 自体脂肪移植在乳腺癌术后乳房重建的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 582-585.
[7] 孙建娜, 孔令军, 任崇禧, 穆坤, 王晓蕊. 266例首诊Ⅳ期乳腺癌手术患者预后分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 502-505.
[8] 宋佳, 汪波, 孙凯律, 商江峰, 吴旦平, 肇毅. 吲哚菁绿荧光显影联合亚甲蓝染色在乳腺癌前哨淋巴结活检中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 498-501.
[9] 张钊, 骆成玉, 张树琦, 何平, 李旭斌. 不同术式治疗早期乳腺癌的效果及并发症发生率、复发率比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 494-497.
[10] 黄程鑫, 陈莉, 刘伊楚, 王水良, 赖晓凤. OPA1 在乳腺癌组织的表达特征及在ER阳性乳腺癌细胞中的生物学功能研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 275-284.
[11] 刘琦, 王守凯, 王帅, 苏雨晴, 马壮, 陈海军, 司丕蕾. 乳腺癌肿瘤内微生物组的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 841-845.
[12] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[13] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[14] 王帅, 张志远, 苏雨晴, 李雯雯, 王守凯, 刘琦, 李文涛. 孟德尔随机化及其在乳腺癌研究中的应用进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 671-676.
[15] 张梦婷, 穷拉姆, 色珍, 李逸群, 德庆旺姆. 西藏地区藏族乳腺癌新辅助化疗的真实世界研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 441-446.
阅读次数
全文


摘要